by The medical information market size accounted for US$ 4.1 billion in 2020 and is projected to hit around US$ 6.4 billion by 2027 and is anticipated to register a CAGR of 9.1% from 2021 to 2027, as per reports by market research and consulting organizations Nova One Advisor.
The report contains 150+ pages with detailed analysis. The report provides an in-depth analysis of the market size, share, emerging and current trends, future estimations, and key players.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.novaoneadvisor.com/report/sample/6101
Report Coverage
| Report Scope | Details |
| Market Size | USD 6.4 Billion by 2027 |
| Growth Rate | CAGR of 9.1% From 2021 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2021 to 2027 |
| Historic Data | 2017 to 2020 |
| Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
| Segments Covered | Service provider, product life cycle, therapeutic area, company size, end-use And Region |
Competition Landscape
In the final section of the research report, Nova One Advisor provided the global medical information market structure and a detailed competition landscape to provide a dashboard view of key players operating in the medical information market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.
Some of the major players in the medical information market include:
IQVIA; Parexel International Corporation; C3i Solutions; PrimeVigilance; McKesson Corporation; Propharma Group; Accenture; Cognizant; Infosys Limited; PharmCentre
Market Report Scope
This market report studies market dynamics, status and outlook especially in North America, Europe and Asia-Pacific, Latin America, the Middle East and Africa. This research report offers scenario and forecast (revenue/volume) and categorizes the market by key players and various segment. This report also studies global market prominence, competitive landscape, market share, growth rates market dynamics such as drivers, restraints and opportunities, and distributors and sales channels.
This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.
Growth Factors:
Increasing demand for new drug development coupled with the emergence of technologically advanced healthcare solutions, timely accessible information pertinent to healthcare products is anticipated to fuel the market growth.
Increasing healthcare expenditure and growing awareness about adverse drug events can increase the possibility of patients seeking medical information. Increase in adoption of social media for discussions on adverse events, ingredients, and other drug-related information.
The market expansion is a result of an increased number of clinical trials and due to the high prevalence of chronic diseases. Moreover, manufacturers of health products are outsourcing MI services to Contract Research Organizations (CROs) to limit the accountability of stringent regulatory compliances by working with a well-established outsourcing partner company. This helps them in reducing operational costs, regulatory compliance risk, and minimizing process delays.
The key factors attributing to the increased demand for outsourcing of medical information services are rising costs of pre-clinical research, drug development, clinical trials, and post-marketing surveillance. The healthcare sector is witnessing paradigm changes in the past decade, due to the depleting product pipeline, patent cliff, and regulatory constraints in new product development. This is expected to boost the adoption of contract outsourcing activities over the forecast period.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Medical Information market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Medical Information market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Medical Information market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis:
North America dominated the industry with a revenue share of 36.2% in 2020. This is attributable to the presence of a well-established regulatory framework in the region. Moreover, the presence of major service providers focusing on novel drug development is expected to fuel the adoption rate of the market for medical information over the forecast period.
Asia Pacific region is anticipated to register a lucrative growth in the forthcoming years owing to the rising awareness among patients, increasing investments and favorable government initiatives for meeting the healthcare demands are the factors driving regional growth. In addition, geographical expansion by various healthcare companies is a major factor that has created a demand for MI solutions. These solutions are generally outsourced to countries such as China and India as they provide skilled labor at a low cost.
Market Segmentation
By Service Provider
- In house
- Contract outsourcing
By Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Immunology
- Others
By Product Life Cycle
- Pre-clinical
- Clinical
- Post Market Approval
By Company Size
- Small
- Medium
- Large Scale
By End-use
- Pharmaceuticals
- Innovators
- Generics
- Biotechnology Companies
- Biologics
- ATMPs
- Biosimilars
- Medical Device Manufacturers
- Therapeutic
- Diagnostic
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
- In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
Most Asked Questions
- What is the market size of the medical information market at the global level?
- Which screen size is most preferred by the consumers of medical information?
- Which mode of distribution channel is most preferred by the manufacturers of medical information?
- Which is the preferred age group for targeting medical information for manufacturers?
- Who are the major players operating in the global medical information market? What is the current market position of the key players? Who are the emerging players in this industry?
- Who are the major distributors, traders, and dealers operating in the medical information market?
- What the key factors driving, inhibiting the growth of the market, and what is the degree of impact of the drivers and restraints?
- What is the impact of the regulations on the growth of the medical information market?
- Which is the leading region/country for the growth of the market? What is the anticipated growth rate of the leading regions during the forecast period?
- How are the emerging markets for medical information expected to perform in the coming years? How is the consumption pattern expected to evolve in the future?
Why should you invest in this report?
If you are aiming to enter the global medical information market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for medical information are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2027, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Purchase Full Research Report (Single User License US$ 3500) @ https://www.novaoneadvisor.com/report/checkout/6101
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Medical Information Market, By Service Provider Type
7.1. Medical Information Market, By Service Provider Type, 2020-2027
7.1.1. In house
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Contract outsourcing
7.1.2.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Medical Information Market, By Therapeutic Area Type
8.1. Medical Information Market, By Therapeutic Area Type, 2020-2027
8.1.1. Oncology
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Neurology
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Cardiology
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Immunology
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Medical Information Market, By Life Cycle Type
9.1. Medical Information Market, By Life Cycle Type, 2020-2027
9.1.1. Pre-clinical
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Clinical
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Post Market Approval
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Medical Information Market, By Company Size Type
10.1. Medical Information Market, By Company Size Type, 2020-2027
10.1.1. Small
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Medium
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Large Scale
10.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global Medical Information Market, By End-use Type
11.1. Medical Information Market, By End-use, 2020-2027
11.1.1. Pharmaceuticals
11.1.1.1. Market Revenue and Forecast (2016-2027)
11.1.2. Biotechnology Companies
11.1.2.1. Market Revenue and Forecast (2016-2027)
11.1.3. Medical Device Manufacturers
11.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 12. Global Medical Information Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.1.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.1.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.1.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.1.5. Market Revenue and Forecast, By End-use (2016-2027)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.1.6.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.1.6.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.1.6.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.1.7. Market Revenue and Forecast, By End-use (2016-2027)
12.1.8. Rest of North America
12.1.8.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.1.8.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.1.8.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.1.8.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.1.8.5. Market Revenue and Forecast, By End-use (2016-2027)
12.2. Europe
12.2.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.2.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.2.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.2.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.2.5. Market Revenue and Forecast, By End-use (2016-2027)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.2.6.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.2.6.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.2.7. Market Revenue and Forecast, By Company Size (2016-2027)
12.2.8. Market Revenue and Forecast, By End-use (2016-2027)
12.2.9. Germany
12.2.9.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.2.9.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.2.9.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.2.10. Market Revenue and Forecast, By Company Size (2016-2027)
12.2.11. Market Revenue and Forecast, By End-use (2016-2027)
12.2.12. France
12.2.12.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.2.12.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.2.12.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.2.12.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.2.13. Market Revenue and Forecast, By End-use (2016-2027)
12.2.14. Rest of Europe
12.2.14.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.2.14.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.2.14.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.2.14.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.2.15. Market Revenue and Forecast, By End-use (2016-2027)
12.3. APAC
12.3.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.3.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.3.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.3.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.3.5. Market Revenue and Forecast, By End-use (2016-2027)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.3.6.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.3.6.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.3.6.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.3.7. Market Revenue and Forecast, By End-use (2016-2027)
12.3.8. China
12.3.8.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.3.8.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.3.8.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.3.8.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.3.9. Market Revenue and Forecast, By End-use (2016-2027)
12.3.10. Japan
12.3.10.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.3.10.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.3.10.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.3.10.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.3.10.5. Market Revenue and Forecast, By End-use (2016-2027)
12.3.11. Rest of APAC
12.3.11.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.3.11.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.3.11.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.3.11.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.3.11.5. Market Revenue and Forecast, By End-use (2016-2027)
12.4. MEA
12.4.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.4.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.4.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.4.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.4.5. Market Revenue and Forecast, By End-use (2016-2027)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.4.6.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.4.6.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.4.6.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.4.7. Market Revenue and Forecast, By End-use (2016-2027)
12.4.8. North Africa
12.4.8.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.4.8.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.4.8.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.4.8.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.4.9. Market Revenue and Forecast, By End-use (2016-2027)
12.4.10. South Africa
12.4.10.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.4.10.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.4.10.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.4.10.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.4.10.5. Market Revenue and Forecast, By End-use (2016-2027)
12.4.11. Rest of MEA
12.4.11.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.4.11.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.4.11.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.4.11.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.4.11.5. Market Revenue and Forecast, By End-use (2016-2027)
12.5. Latin America
12.5.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.5.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.5.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.5.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.5.5. Market Revenue and Forecast, By End-use (2016-2027)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.5.6.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.5.6.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.5.6.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.5.7. Market Revenue and Forecast, By End-use (2016-2027)
12.5.8. Rest of LATAM
12.5.8.1. Market Revenue and Forecast, By Service Provider (2016-2027)
12.5.8.2. Market Revenue and Forecast, By Therapeutic Area (2016-2027)
12.5.8.3. Market Revenue and Forecast, By Life Cycle (2016-2027)
12.5.8.4. Market Revenue and Forecast, By Company Size (2016-2027)
12.5.8.5. Market Revenue and Forecast, By End-use (2016-2027)
Chapter 13. Company Profiles
13.1. Accenture plc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Infosys Limited
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. PAREXEL International Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. IQVIA
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. C3i Solutions
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. McKesson Corporation
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. PriemVigilance
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Propharma Group
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Cognizant
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. PharmCentre
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 3500) @ https://www.novaoneadvisor.com/report/checkout/6101
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@novaoneadvisor.com
